Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational and Cross-Sectional Cohort Study of the Natural History and Phenotypic Spectrum of Farber Disease

NCT03233841 is registered in ClinicalTrials.gov with Sumitomo Pharma Switzerland GmbH as lead sponsor.

NCT NCT03233841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03233841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational and Cross-Sectional Cohort Study of the Natural History and Phenotypic Spectrum of Farber Disease
Lead sponsor
Sumitomo Pharma Switzerland GmbH
Phase
Observational
Overall status
Completed
Start date
November 22, 2017
Completion date
December 9, 2019
Enrollment
45 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

acid ceramidase deficiency, asah1 mutation, ceramidase deficiency, farber disease, farber lipogranulomatosis, farber's disease, n-laurylsphingosine deacylase deficiency